IL148963A0 - Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba - Google Patents

Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Info

Publication number
IL148963A0
IL148963A0 IL14896300A IL14896300A IL148963A0 IL 148963 A0 IL148963 A0 IL 148963A0 IL 14896300 A IL14896300 A IL 14896300A IL 14896300 A IL14896300 A IL 14896300A IL 148963 A0 IL148963 A0 IL 148963A0
Authority
IL
Israel
Prior art keywords
carnitine
extracts
prevention
derivatives
treatment
Prior art date
Application number
IL14896300A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of IL148963A0 publication Critical patent/IL148963A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14896300A 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba IL148963A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000618A IT1306722B1 (it) 1999-10-08 1999-10-08 Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
PCT/IT2000/000391 WO2001026666A2 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Publications (1)

Publication Number Publication Date
IL148963A0 true IL148963A0 (en) 2002-11-10

Family

ID=11406992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14896300A IL148963A0 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Country Status (21)

Country Link
US (1) US6641849B1 (es)
EP (1) EP1218022B1 (es)
AR (1) AR025790A1 (es)
AT (1) ATE237341T1 (es)
AU (1) AU780643B2 (es)
CA (1) CA2386770C (es)
CZ (1) CZ20021062A3 (es)
DE (1) DE60002226T2 (es)
DK (1) DK1218022T3 (es)
ES (1) ES2195939T3 (es)
HU (1) HU227042B1 (es)
IL (1) IL148963A0 (es)
IT (1) IT1306722B1 (es)
MX (1) MXPA02003501A (es)
NO (1) NO20021640L (es)
PL (1) PL199996B1 (es)
PT (1) PT1218022E (es)
SK (1) SK4052002A3 (es)
TN (1) TNSN00186A1 (es)
TR (1) TR200200948T2 (es)
WO (1) WO2001026666A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
KR20030088453A (ko) * 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ATE497809T1 (de) 2004-05-18 2011-02-15 Bright Future Pharmaceutical Lab Ltd Myricitrin verbindungen zur behandlung von schlafstörungen
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
ITRM20040561A1 (it) * 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
AR070816A1 (es) * 2008-03-14 2010-05-05 Otsuka Pharma Co Ltd Farmaco de combinacion para tratar trastornos vasculares
AU2009315771A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CZ308282B6 (cs) * 2010-08-05 2020-04-15 Výzkumný ústav živočišné výroby, v. v. i. Krmný doplněk pro zvýšení libida kanců
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
PL2952209T3 (pl) * 2014-06-04 2018-07-31 Alfasigma S P A Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE9318632U1 (de) * 1993-12-06 1995-04-06 Emsa-Werke Wulf GmbH & Co, 48282 Emsdetten Vorrichtung zum Aufnehmen von Folienrollen
US6221356B1 (en) * 1996-12-13 2001-04-24 Viva America Marketing, Inc. Method of preparation of biologically active Ginkgo biloba product
WO1998033494A1 (en) 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.

Also Published As

Publication number Publication date
TNSN00186A1 (fr) 2005-11-10
ATE237341T1 (de) 2003-05-15
EP1218022A2 (en) 2002-07-03
US6641849B1 (en) 2003-11-04
CZ20021062A3 (cs) 2002-08-14
PL199996B1 (pl) 2008-11-28
MXPA02003501A (es) 2002-09-02
NO20021640D0 (no) 2002-04-05
WO2001026666A2 (en) 2001-04-19
ITRM990618A0 (it) 1999-10-08
AR025790A1 (es) 2002-12-11
AU780643B2 (en) 2005-04-07
HU227042B1 (en) 2010-05-28
DE60002226D1 (de) 2003-05-22
WO2001026666A3 (en) 2001-09-13
ES2195939T3 (es) 2003-12-16
PL354413A1 (en) 2004-01-12
ITRM990618A1 (it) 2001-04-08
CA2386770C (en) 2009-09-08
DK1218022T3 (da) 2003-08-11
DE60002226T2 (de) 2004-03-04
SK4052002A3 (en) 2002-09-10
AU7945600A (en) 2001-04-23
HUP0203449A3 (en) 2005-04-28
NO20021640L (no) 2002-05-29
TR200200948T2 (tr) 2002-10-21
HUP0203449A2 (hu) 2003-02-28
PT1218022E (pt) 2003-09-30
IT1306722B1 (it) 2001-10-02
CA2386770A1 (en) 2001-04-19
EP1218022B1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
IL146703A0 (en) Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
GB0024213D0 (en) Composition from ginkgo biloba leaves preparation and uses
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
IL148963A0 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
EP1406648A4 (en) USE OF ANGIOTENSIN I DERIVATIVE AGENT FOR THE TREATMENT AND PREVENTION OF INFECTIOUS HEART DAMAGE AND DISEASES
AU7601400A (en) Treatment and prevention of hepatic disorders
HUP0203379A3 (en) Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
HUP0204209A3 (en) Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
HUP0204467A3 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
IL143903A0 (en) Use of phanquinone for the treatment or prevention of memory impairment
HUP0301847A3 (en) Use of adatanserin for producing pharmaceutical compositions for the treatment and prevention of neurodegenerative conditions
HUP9902469A3 (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL132664A (en) Method for sterilization and for the prevention of outcrop of catha edulis forsk
EP1194162A4 (en) COMPOSITIONS AND METHODS OF PREVENTING, TREATING AND DETECTING TUBERHULOSIS AND OTHER DISEASES
HU9904440D0 (en) Pharmaceutical composition for the prevention and the treatment of fungus-infected and process producing the agents
AUPQ212899A0 (en) Composition & method for the prevention & treatment of skin disorders